Melatonin is a potential drug for the prevention of bone loss during space flight

Melatonin is a potential drug for the prevention of bone loss during space flight
(a) A goldfish and a binocular view of an ontogenic scale. Grooves radiate from the center focus. (b) Binocular views of a regenerating scale on day 14 (left) and the same scale stained for TRAP activity, indicated by the red color along the grooves (right). The grooves formed a mesh-like structure at the center of the goldfish scales. (c) Light microscopic views of the surface on the osseous layer of the regenerating goldfish scales cultured for 86 h at 22°C on the ground. TRAP staining (left) and F-actin staining (right) superimposed with DAPI staining of the nuclei. A TRAP-positive multinucleated osteoclast possessed an actin ring along the groove. (d) Schematic illustration of morphological features of goldfish scales. Fish scales can regenerate following scale removal. On the groove edge of the goldfish scales, a multinucleated osteoclast exhibited a well-developed RB and CZs (e). Active cuboidal osteoblasts (f) are observed at the periphery and on the dermis side of the scale. They represent a highly-developed rER and Go. OB, osteoblast; OC, osteoclast; TRAP, tartrate-resistant acid phosphatase; DAPI, 4', 6-diamidino-2-phenylindole; N, nucleus; RB, ruffled border; CZ, clear zone; rER, rough endoplasmic reticulum; Go, Golgi apparatus. Scale bars = 1 mm in a and b, 10 μm in c, 5 μm in e and f. Credit: Kanazawa University

Melatonin could be a novel drug for preventing bone loss to astronauts during space flight. Here we used goldfish scales as a bone model of coexisting osteoclasts and osteoblasts and demonstrated that melatonin synthesis decreased under microgravity. Melatonin treatment of scales stimulated expression of Calcitonin, an osteoclast-inhibiting hormone, and decreased expression of an osteoclastogenesis promotor. This is the first study to report the inhibitory effect of melatonin on osteoclast activation, which is cancelled by microgravity.

For proper and healthy metabolism of , appropriate stimuli are necessary. In outer space with microgravity, calcium is lost from bone and bone mass is reduced. Measurement of the bone density of astronauts before and after a long stay in outer space indicates bone mass loss. At the dawn of an era where astronauts are to stay for a long period of time in an international space station, it is an urgent task to elucidate changes of osteoblasts and osteoclasts under microgravity conditions and to perform research on potential drugs as remedies. Since it is difficult in outer space to use a that meets in vivo conditions, other experimental models are necessary.

The present research group, consisting of 53 scientists from 33 institutions, led by scientists from Kanazawa University, Tokyo Medical and Dental University, Okayama University and University of Toyama, used cultured goldfish scales to investigate the mechanism of bone loss in space. A scale contains hydroxyapatite, a fundamental element of bone, and its bone matrix of two layers (osseous layer: a thin, well-calcified external layer; and a fibrillary layer: a thick, partially calcified layer). A scale also has cells corresponding to osteoblasts and osteoclasts (Figure 1). Scales protect the surface of the fish body and play a role as a reservoir of calcium. With freshwater fish, the latter function is noteworthy; when salmon swim upstream to lay eggs, it is known that their scales get smaller in order to supply calcium to the eggs. To achieve this, osteoclasts release calcium from the scales. In addition, ground-based experiments reveal that the responses of scales to hormones and extra-gravity due to centrifugation are very similar to those of mammalian bones. Furthermore, cultured scales may be considered to be an excellent experimental model for research of bone metabolism in outer space since scales are readily available and they can be used for experiments for about 10 days at a low temperature (4ºC) without exchanging culture media.

Melatonin is a potential drug for the prevention of bone loss during space flight
(a) N-acetylserotonin O-methyltransferase (Asmt) mRNA expression levels in the regenerating scales during space flight in artificial gravity (F-1g) or microgravity (F-μg), and on the ground analyzed using real-time PCR. (b-e) mRNA expression levels of osteoclast-related factors: matrix metalloproteinase-9 (Mmp-9) (b), cathepsin K (Ctsk) (c), receptor activator of nuclear factor κβ ligand (Rankl) (d), and Calcitonin (e). F-1g, flight 1g; F-μg, flight microgravity; F-μg + Mel, F-μg treated with melatonin (1 μM). All targets were standardized to elongation factor 1 alpha expression levels and presented as relative ratios. All data are mean ± SEM (n = 4); *P < 0.05, **P < 0.01. Credit: Kanazawa University

Upon removal of a scale from fish skin, a new scale is regenerated. In this study, regenerated scales were used since their osteoblast and osteoclast activities are high. First it was shown that melatonin was produced in scale osteoblasts and that melatonin synthesis decreased in space due to reduced expression of acetylserotonin O-methyltransferase, an enzyme important in melatonin synthesis (Figure 2a).

Further, melatonin functions in outer space were investigated by comparing scales cultured in a media supplemented with melatonin and those without. This experiment revealed that after a three-day culture in melatonin-free media, a number of osteoclasts fused together to form multinucleated, active osteoclasts. These active osteoclasts widened the grooves of a scale's osseous layer and enhanced bone resorption of scales. Moreover, the expression level of the Rankl gene, a factor enhancing bone resorption, was elevated while the expression level of the Calcitonin gene, a hormone suppressing bone resorption, was repressed. In contrast, in scales cultured in a media supplemented with melatonin, the expression level of Rankl was found to be repressed while Calcitonin expression was at a normal level, which coincided with suppressed gene expression levels for functions (Figures 2b-e).

To our knowledge, no investigations have so far been performed on melatonin levels in outer space. We believe that one of the mechanisms of bone resorption under microgravity conditions could be a decrease of melatonin level to suppress CALCITONIN secretion (Figure 3). In fact, other research groups reported that the blood CALCITONIN level of a monkey decreased in outer space and that the CALCITONIN level in the blood of human subjects decreased after 120 days on a head-down tilt bed rest, a pseudo-microgravity experimental model.

Melatonin is a potential drug for the prevention of bone loss during space flight
Lower frame: We observed the expression of melatonin receptor (Mel-R), melatonin synthesizing enzyme (ASMT), and CALCITONIN (an osteoclast-inhibiting hormone) in osteoblasts in regenerating goldfish scales. Melatonin stimulated CALCITONIN production in the scales, which has also been detected in mammalian bones. The autocrine and paracrine effects of melatonin could stimulate CALCITONIN production in scales, in turn suppressing osteoclast activity. Upper frame: Microgravity during space flight accelerated the multinucleation and resorption activity in scale osteoclasts, which was associated with the stimulated gene expression of Rankl (a major factor for osteoclastogenesis) and the suppressed gene expression of Calcitonin. Melatonin administration maintained the normal gene expression levels of the factors during space flight and suppressed microgravity-stimulated osteoclast activity. The results suggest that melatonin could be used as a prophylactic drug to prevent bone loss in astronauts during space flight. OB, osteoblasts; OC, osteoclasts; POC, preosteoclasts; RANKL, receptor activator of nuclear factor κB ligand; Mel, melatonin; Mel-R, melatonin receptor; CALCITONIN-R, CALCITONIN receptor; ASMT: N-acetylserotonin O-methyltransferase; ISS, the International Space Station. Credit: Kanazawa University

The present research group confirmed in ground based experiments that scale osteoblasts produced CALCITONIN and that melatonin enhanced CALCITONIN secretion. Due to the limitation of rocket load, experiments on morphological changes of osteoclasts due to melatonin were not possible in outer space at this time; however, ground based experiments indicated suppression of morphological changes of activated osteoclasts by melatonin by using a three-dimensional clinostat, which produces pseudo-microgravity conditions. A research paper with these results was published in a high impact factor journal based on life science experiments performed in the Japanese Experiment Module for the first time.

As above, investigation of melatonin action on bones in , which had been neglected so far, revealed that melatonin suppresses bone resorption by stimulating osteoblasts to secret CALCITONIN (Figure 3).

The present study indicates the possibility that melatonin could serve as a prophylactic drug to prevent bone loss of astronauts during their missions. Melatonin is expected to be used as a preventive and curative drug for loss of bones of astronauts in the future. The present research group performs in- experiments on the functions of new derivatives on scales, which may lead to drug discovery of bone diseases.


Explore further

Study identifies protein responsible for mechanism behind bone loss

More information: Mika Ikegame et al, Melatonin is a potential drug for the prevention of bone loss during space flight, Journal of Pineal Research (2019). DOI: 10.1111/jpi.12594
Citation: Melatonin is a potential drug for the prevention of bone loss during space flight (2019, September 3) retrieved 16 November 2019 from https://medicalxpress.com/news/2019-09-melatonin-potential-drug-bone-loss.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments